In partnership with
Explore Medicom's coverage of the 19th IASLC World Conference on Lung Cancer (WCLC) through this collection of 24 articles.
Letter from The Editor
Interview with the IASCL President
Durvalumab after chemoradiotherapy extends OS in stage 3, unresectable non-small-cell lung cancer
Potential for brigatinib as a first-line treatment option for ALK+ non-small-cell lung cancer
Benefits of chest CT screening
New standard of care in extensive-stage small-cell lung cancer
No progression-free survival benefit with nintedanib plus pemetrexed/cisplatin for malignant pleural mesothelioma of epithelial subtype
Next generation immunotherapy in non-small-cell lung cancer
Combination therapies: Where are we in 2018?
Choice of taxane and addition of pembrolizumab for metastatic squamous non-small-cell lung cancer
PD-L1 expression in untreated EGFR-mutant non-small-cell lung cancer and response to osimertinib
Accumulation of concomitant mutations involved in drug resistance in sequential ALK TKI treatments of ALK-positive NSCLC
Crizotinib-treated ALK IHC-positive advanced NSCLC is associated with an unfavourable prognosis when FISH negative
Unmet needs in surgical management of malignant pleural mesothelioma
Angiogenic and stromal biomarkers in malignant mesothelioma
Patient-reported outcomes of first-line nivolumab + ipilimumab in high tumour mutational burden advanced non-small-cell lung cancer
Avelumab vs docetaxel for previously treated advanced non-small-cell lung cancer
Effects of dose modifications on safety and efficacy of dacomitinib for EGFR-mutant non-small-cell lung cancer
Osimertinib and RET inhibitor BLU-667 in an EGFR-mutant patient with acquired RET rearrangement
Central nervous system activity of ramucirumab + osimertinib in patients with advanced T790M-positive EGFR-mutant non-small-cell lung cancer
Entrectinib treatment in patients with ROS1+ NSCLC
Small-cell lung cancer circulating tumour cell derived explants
Spread through air spaces is prognostic in lung neuroendocrine tumours
Prognostic value of distant organ-specific metastases in newly diagnosed lung neuroendocrine tumours
The content and interpretation of these conference highlights are the views and comments of the speakers/ authors.
BACK TO TOP